- Home
- ANIP vs ETV Comparison
ANIP vs ETV Comparison
Compare ANIP & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- ETV
- Stock Information
- Founded
- ANIP 2001
- ETV 2005
- Country
- ANIP United States
- ETV United States
- Employees
- ANIP N/A
- ETV N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- ETV Investment Managers
- Sector
- ANIP Health Care
- ETV Finance
- Exchange
- ANIP Nasdaq
- ETV Nasdaq
- Market Cap
- ANIP 1.4B
- ETV 1.6B
- IPO Year
- ANIP N/A
- ETV N/A
- Fundamental
- Price
- ANIP $64.03
- ETV $13.78
- Analyst Decision
- ANIP Strong Buy
- ETV
- Analyst Count
- ANIP 9
- ETV 0
- Target Price
- ANIP $80.56
- ETV N/A
- AVG Volume (30 Days)
- ANIP 303.6K
- ETV 252.5K
- Earning Date
- ANIP 08-05-2025
- ETV 01-01-0001
- Dividend Yield
- ANIP N/A
- ETV 8.75%
- EPS Growth
- ANIP N/A
- ETV N/A
- EPS
- ANIP N/A
- ETV N/A
- Revenue
- ANIP $674,068,000.00
- ETV N/A
- Revenue This Year
- ANIP $30.84
- ETV N/A
- Revenue Next Year
- ANIP $7.39
- ETV N/A
- P/E Ratio
- ANIP N/A
- ETV N/A
- Revenue Growth
- ANIP 30.27
- ETV N/A
- 52 Week Low
- ANIP $52.50
- ETV $11.05
- 52 Week High
- ANIP $77.00
- ETV $13.50
- Technical
- Relative Strength Index (RSI)
- ANIP 44.50
- ETV 53.90
- Support Level
- ANIP $65.68
- ETV $13.75
- Resistance Level
- ANIP $68.18
- ETV $13.83
- Average True Range (ATR)
- ANIP 2.29
- ETV 0.10
- MACD
- ANIP -0.27
- ETV -0.02
- Stochastic Oscillator
- ANIP 13.00
- ETV 44.87
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.